Hoopoe Holding, the first AI-powered, IP-protected wellness franchise, is rapidly progressing toward its ambitious global ...
Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 Designation earned for one-time AAV gene therapy SAR446268, designed to silence DMPK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback